Skip to main content
. 2021 Mar 9;4(4):e1354. doi: 10.1002/cnr2.1354

FIGURE 3.

FIGURE 3

Overall survival of patients undergoing induction chemotherapy. This figure demonstrates the overall survival for patients who underwent induction chemotherapy (defined as receiving an anthracycline and cytarabine; liposomal daunorubicin and cytarabine; mitoxantrone, etoposide and cytarabine; etoposide and cytarabine; or treated on a clinical trial of induction‐based chemotherapy) stratified by area of geographic residency